Sublingual Immunotherapy
Treatment
Notes: Patients should be trained how to use the device, instructed on how to recognize and manage adverse reactions and missed doses, and advised on when to contact their physician or other health care professional. Recommendations for when to withhold the SLIT tablet dose to avoid potential situations when systemic allergic reactions may be more likely should also be provided.
Recommendation Grading
Disclaimer
Overview
Title
Sublingual Immunotherapy
Authoring Organizations
American College of Allergy, Asthma, and Immunology
American Academy of Allergy, Asthma & Immunology
Publication Month/Year
May 1, 2017
Last Updated Month/Year
August 2, 2023
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Target Patient Population
Adults and children taking sublingual immunotherapy
Target Provider Population
Allergists, ENTs, Family Physicians and other providers managing patients taking SLITs
Inclusion Criteria
Female, Male, Adult, Child, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Management
Diseases/Conditions (MeSH)
D063729 - Sublingual Immunotherapy
Keywords
sublingual immunotherapy, ragweed, allergen, allergic rhinitis immunotherapy, SLIT, allergy drops, grassweed
Source Citation
Greenhawt M, Oppenheimer J, Nelson MN, et al. Sublingual immunotherapy. Ann Allergy Asthma Immunol. 2017;118(3):276-282.e2.